Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Alcoholic Liver Disease: Pathogenesis and Current Management.

Osna NA, Donohue TM Jr, Kharbanda KK.

Alcohol Res. 2017;38(2):147-161.

2.

Gutuo Jiejiu decoction improves survival of patients with severe alcoholic hepatitis: A retrospective cohort study.

Mou HY, Nie HM, Hu XY.

World J Gastroenterol. 2017 Apr 28;23(16):2957-2963. doi: 10.3748/wjg.v23.i16.2957.

3.

Infections in severe alcoholic hepatitis.

Karakike E, Moreno C, Gustot T.

Ann Gastroenterol. 2017;30(2):152-160. doi: 10.20524/aog.2016.0101. Epub 2016 Oct 27. Review.

4.

Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA Institute.

Mitchell MC, Friedman LS, McClain CJ.

Clin Gastroenterol Hepatol. 2017 Jan;15(1):5-12. doi: 10.1016/j.cgh.2016.08.047. Review.

PMID:
27979049
5.

Practical Concerns and Controversies in the Management of Alcoholic Hepatitis.

Im GY, Lucey MR.

Gastroenterol Hepatol (N Y). 2016 Aug;12(8):478-489.

6.

Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials.

Njei B, Do A, McCarty TR, Fortune BE.

J Clin Gastroenterol. 2016 Nov/Dec;50(10):871-881.

PMID:
27404293
7.

Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune Cells.

Kim KH, Lee JM, Zhou Y, Harpavat S, Moore DD.

Mol Endocrinol. 2016 Aug;30(8):905-16. doi: 10.1210/me.2016-1029. Epub 2016 Jun 29.

8.

Current Management of Alcoholic Hepatitis and Future Therapies.

Saberi B, Dadabhai AS, Jang YY, Gurakar A, Mezey E.

J Clin Transl Hepatol. 2016 Jun 28;4(2):113-22. doi: 10.14218/JCTH.2016.00006. Epub 2016 Jun 15. Review.

9.

Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review.

Singal AK, Kodali S, Vucovich LA, Darley-Usmar V, Schiano TD.

Alcohol Clin Exp Res. 2016 Jul;40(7):1390-402. doi: 10.1111/acer.13108. Epub 2016 Jun 2. Review.

10.

Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Kim MS, Ong M, Qu X.

World J Gastroenterol. 2016 Jan 7;22(1):8-23. doi: 10.3748/wjg.v22.i1.8. Review.

11.

Alcoholic hepatitis: The pivotal role of Kupffer cells.

Suraweera DB, Weeratunga AN, Hu RW, Pandol SJ, Hu R.

World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):90-8. doi: 10.4291/wjgp.v6.i4.90.

12.

Advances in alcoholic liver disease: An update on alcoholic hepatitis.

Liang R, Liu A, Perumpail RB, Wong RJ, Ahmed A.

World J Gastroenterol. 2015 Nov 14;21(42):11893-903. doi: 10.3748/wjg.v21.i42.11893. Review.

13.

Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best?

Amieva-Balmori M, Mejia-Loza SM, Ramos-González R, Zamarripa-Dorsey F, García-Ruiz E, Pérez Y López N, Juárez-Valdés EI, López-Luria A, Remes-Troche JM.

World J Hepatol. 2015 Aug 18;7(17):2119-26. doi: 10.4254/wjh.v7.i17.2119.

14.

Prognostic models for alcoholic hepatitis.

Rahimi E, Pan JJ.

Biomark Res. 2015 Jul 21;3:20. doi: 10.1186/s40364-015-0046-z. eCollection 2015.

15.

Trends in the management and burden of alcoholic liver disease.

Mathurin P, Bataller R.

J Hepatol. 2015 Apr;62(1 Suppl):S38-46. doi: 10.1016/j.jhep.2015.03.006. Review.

16.

Assessment of the Model for End-stage Liver Disease (MELD) Score in Predicting Prognosis of Patients with Alcoholic Hepatitis.

Goyal SK, Dixit VK, Jain AK, Mohapatra PK, Ghosh JK.

J Clin Exp Hepatol. 2014 Mar;4(1):19-24. doi: 10.1016/j.jceh.2014.02.006. Epub 2014 Feb 27.

17.

Alcoholic hepatitis and HCV interactions in the modulation of liver disease.

Punzalan CS, Bukong TN, Szabo G.

J Viral Hepat. 2015 Oct;22(10):769-76. doi: 10.1111/jvh.12399. Epub 2015 Mar 6. Review.

18.

Alcoholic hepatitis: a comprehensive review of pathogenesis and treatment.

Chayanupatkul M, Liangpunsakul S.

World J Gastroenterol. 2014 May 28;20(20):6279-86. doi: 10.3748/wjg.v20.i20.6279. Review.

19.

Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.

Papastergiou V, Tsochatzis EA, Pieri G, Thalassinos E, Dhar A, Bruno S, Karatapanis S, Luong TV, O'Beirne J, Patch D, Thorburn D, Burroughs AK.

Aliment Pharmacol Ther. 2014 Apr;39(7):721-32.

20.

Therapy for alcoholic liver disease.

Jaurigue MM, Cappell MS.

World J Gastroenterol. 2014 Mar 7;20(9):2143-58. doi: 10.3748/wjg.v20.i9.2143. Review.

Supplemental Content

Support Center